Stay updated on Safety of Iptacopan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety of Iptacopan in IgA Nephropathy Clinical Trial page
- Check3 days agoChange DetectedThe study history gains a Contacts/Locations section and an updated Study Status, corresponding to revision v3.6.3 released on 2026-07-01.SummaryDifference0.5%

- Check10 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of v3.6.0, reflecting a software version update for the study history page.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRecruitment status was updated to 'No longer looking for participants,' indicating enrollment closure. A new revision tag 'Revision: v3.6.0' was added to the history, replacing the previous 'Revision: v3.5.5'.SummaryDifference0.3%

- Check31 days agoChange DetectedVersion v3.5.5 (2026-06-01) updates the record to Active, not recruiting and adjusts associated fields such as Study Status, Contacts/Locations, and Study Design. This revision replaces the prior v3.5.4 (2026-05-06) which showed the Recruiting status.SummaryDifference0.7%

- Check53 days agoChange DetectedThe revision history now includes a new entry for Revision: v3.5.4, replacing the previous v3.5.3. This signals an updated page version at the history level, with no changes to the study data.SummaryDifference0.1%

- Check60 days agoChange DetectedNew history entries were added for Contacts/Locations and Study Status with a 2026-05-04 version and a 2026-05-06 update, representing updated contact details, locations, and the study's current recruitment status in the record history.SummaryDifference0.4%

Stay in the know with updates to Safety of Iptacopan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.